一名既往接受过治疗、伴有较差体能状态的转移性肾细胞癌患者对替西罗莫司产生持久反应。 - Suppr

Suppr

超能文献

Prolonged response to temsirolimus in a pre-treated patient with metastatic renal cell carcinoma and poor performance status.

作者信息

Jafri M, Douis H, Porfiri E

出版信息

Clin Oncol (R Coll Radiol). 2008 Oct;20(8):657-8. doi: 10.1016/j.clon.2008.06.002. Epub 2008 Jul 21.

DOI:10.1016/j.clon.2008.06.002

PMID:18644704

Abstract

摘要

相似文献

Prolonged response to temsirolimus in a pre-treated patient with metastatic renal cell carcinoma and poor performance status.

Clin Oncol (R Coll Radiol). 2008 Oct;20(8):657-8. doi: 10.1016/j.clon.2008.06.002. Epub 2008 Jul 21.

Temsirolimus (Torisel) for advanced renal cell carcinoma.

Med Lett Drugs Ther. 2007 Dec 17;49(1276):103-4.

Temsirolimus for metastatic desmoplastic small round cell tumor.

Pediatr Blood Cancer. 2010 Dec 15;55(7):1431-2. doi: 10.1002/pbc.22755.

Temsirolimus for advanced renal cell carcinoma.

Clin Adv Hematol Oncol. 2007 Nov;5(11):893.

Mechanisms of Disease: survival benefit of temsirolimus validates a role for mTOR in the management of advanced RCC.

Nat Clin Pract Oncol. 2008 Oct;5(10):601-9. doi: 10.1038/ncponc1173. Epub 2008 Jul 8.

Tumour flare during interruption of temsirolimus treatment for metastatic renal cell cancer.

Clin Oncol (R Coll Radiol). 2009 Nov;21(9):732-3. doi: 10.1016/j.clon.2009.07.006. Epub 2009 Aug 7.

Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma.

Clin J Oncol Nurs. 2008 Aug;12(4):639-46. doi: 10.1188/08.CJON.639-646.

[Clinical observation of 21 cases of metastatic renal cell carcinoma treated with sorafenib].

Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):714-5.

Temsirolimus in patients with advanced renal cell carcinoma: an overview.

Adv Ther. 2009 Jan;26(1):55-67. doi: 10.1007/s12325-008-0138-3. Epub 2009 Jan 26.

Molecule of the month. Temsirolimus.

Drug News Perspect. 2007 Jul-Aug;20(6):406.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Prolonged response to temsirolimus in a pre-treated patient with metastatic renal cell carcinoma and poor performance status.

作者信息

Jafri M, Douis H, Porfiri E

出版信息

Clin Oncol (R Coll Radiol). 2008 Oct;20(8):657-8. doi: 10.1016/j.clon.2008.06.002. Epub 2008 Jul 21.

DOI:10.1016/j.clon.2008.06.002

PMID:18644704

Abstract

摘要

相似文献

Prolonged response to temsirolimus in a pre-treated patient with metastatic renal cell carcinoma and poor performance status.

Clin Oncol (R Coll Radiol). 2008 Oct;20(8):657-8. doi: 10.1016/j.clon.2008.06.002. Epub 2008 Jul 21.

Temsirolimus (Torisel) for advanced renal cell carcinoma.

Med Lett Drugs Ther. 2007 Dec 17;49(1276):103-4.

Temsirolimus for metastatic desmoplastic small round cell tumor.

Pediatr Blood Cancer. 2010 Dec 15;55(7):1431-2. doi: 10.1002/pbc.22755.

Temsirolimus for advanced renal cell carcinoma.

Clin Adv Hematol Oncol. 2007 Nov;5(11):893.

Mechanisms of Disease: survival benefit of temsirolimus validates a role for mTOR in the management of advanced RCC.

Nat Clin Pract Oncol. 2008 Oct;5(10):601-9. doi: 10.1038/ncponc1173. Epub 2008 Jul 8.

Tumour flare during interruption of temsirolimus treatment for metastatic renal cell cancer.

Clin Oncol (R Coll Radiol). 2009 Nov;21(9):732-3. doi: 10.1016/j.clon.2009.07.006. Epub 2009 Aug 7.

Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma.

Clin J Oncol Nurs. 2008 Aug;12(4):639-46. doi: 10.1188/08.CJON.639-646.

[Clinical observation of 21 cases of metastatic renal cell carcinoma treated with sorafenib].

Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):714-5.

Temsirolimus in patients with advanced renal cell carcinoma: an overview.

Adv Ther. 2009 Jan;26(1):55-67. doi: 10.1007/s12325-008-0138-3. Epub 2009 Jan 26.

Molecule of the month. Temsirolimus.

Drug News Perspect. 2007 Jul-Aug;20(6):406.